The company will debut its new excipient portfolio, StabiliPro, at SupplySide Global 2025 in Las Vegas
A new survey reveals deep scepticism toward AI-generated regulatory materials, with pharma teams citing hallucinations, poor auditability and lack of transparency as major risks
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.